Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-015285

Co-CEO gave up 361,980 shares (to pay taxes)

  • Co-CEO acquired 886,468 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Chintu Co-CEO 2026-03-03 Option exercise +59,931 923,964 D
Patel Chintu Co-CEO 2026-03-03 Shares withheld for taxes −17,112 $13.31 $227,761 906,852 D
Patel Chintu Co-CEO 2026-03-03 Option exercise +733,944 1,640,796 D
Patel Chintu Co-CEO 2026-03-03 Shares withheld for taxes −315,885 $13.31 $4,204,429 1,324,911 D
Patel Chintu Co-CEO 2026-03-04 Option exercise +92,593 1,417,504 D
Patel Chintu Co-CEO 2026-03-04 Shares withheld for taxes −28,983 $13.30 $385,474 1,388,521 D
Derivatives
Patel Chintu Co-CEO 2026-03-03 Option exercise · Restricted Stock Units −59,931 179,795 D
Patel Chintu Co-CEO 2026-03-03 Option exercise · Performance-Based Restricted Stock Units −733,944 0 D
Patel Chintu Co-CEO 2026-03-04 Option exercise · Restricted Stock Units −92,593 185,185 D
Loading xslF345X05/wk-form4_1772747542.xml…